West Pharmaceutical Services PE Ratio 2010-2024 | WST

Current and historical p/e ratio for West Pharmaceutical Services (WST) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. West Pharmaceutical Services PE ratio as of February 28, 2025 is 32.75.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

West Pharmaceutical Services PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-02-28 232.34 34.73
2024-12-31 327.56 $6.69 48.96
2024-09-30 299.98 $6.74 44.51
2024-06-30 328.97 $7.03 46.80
2024-03-31 395.01 $7.58 52.11
2023-12-31 351.31 $7.88 44.58
2023-09-30 374.35 $7.41 50.52
2023-06-30 381.40 $6.86 55.60
2023-03-31 345.31 $7.28 47.43
2022-12-31 234.39 $7.72 30.36
2022-09-30 244.87 $8.29 29.54
2022-06-30 300.70 $9.01 33.37
2022-03-31 408.25 $9.00 45.36
2021-12-31 465.98 $8.70 53.56
2021-09-30 421.61 $8.06 52.31
2021-06-30 356.46 $6.84 52.11
2021-03-31 279.56 $5.58 50.10
2020-12-31 280.92 $4.58 61.34
2020-09-30 272.42 $4.13 65.96
2020-06-30 224.98 $3.79 59.36
2020-03-31 150.64 $3.46 43.54
2019-12-31 148.59 $3.20 46.43
2019-09-30 140.01 $3.05 45.91
2019-06-30 123.41 $3.03 40.73
2019-03-31 108.52 $2.90 37.42
2018-12-31 96.40 $2.75 35.05
2018-09-30 121.26 $2.06 58.86
2018-06-30 97.37 $2.00 48.69
2018-03-31 86.45 $1.76 49.12
2017-12-31 96.48 $1.99 48.48
2017-09-30 93.98 $2.51 37.44
2017-06-30 92.15 $2.34 39.38
2017-03-31 79.44 $2.43 32.69
2016-12-31 82.45 $1.92 42.94
2016-09-30 72.28 $1.85 39.07
2016-06-30 73.50 $1.37 53.65
2016-03-31 67.04 $1.15 58.29
2015-12-31 58.11 $1.30 44.70
2015-09-30 52.11 $1.28 40.71
2015-06-30 55.83 $1.69 33.03
2015-03-31 57.76 $1.83 31.56
2014-12-31 50.97 $1.76 28.96
2014-09-30 42.74 $1.66 25.75
2014-06-30 40.18 $1.60 25.11
2014-03-31 41.86 $1.51 27.73
2013-12-31 46.53 $1.58 29.45
2013-09-30 38.95 $1.55 25.13
2013-06-30 33.16 $1.40 23.77
2013-03-31 30.56 $1.19 25.68
2012-12-31 25.68 $1.15 22.42
2012-09-30 24.80 $1.12 22.24
2012-06-30 23.51 $1.15 20.53
2012-03-31 19.72 $1.21 16.36
2011-12-31 17.51 $1.08 16.21
2011-09-30 17.04 $0.90 18.93
2011-06-30 20.02 $0.91 22.00
2011-03-31 20.40 $0.94 21.82
2010-12-31 18.70 $0.94 19.89
2010-09-30 15.50 $1.15 13.54
2010-06-30 16.41 $1.14 14.39
2010-03-31 18.79 $1.12 16.86
2009-12-31 17.49 $1.06 16.50
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $15.984B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47